Skip to main content

Sienna Biopharmaceuticals is focused on the discovery, clinical development and commercialization of products in dermatology and aesthetics based on scientific breakthroughs that dramatically improve patient outcomes, and physicians’ practice of medicine.

Recent News

Sienna Biopharmaceuticals Announces Second Closing of Series A Financing

Sienna Biopharmaceuticals, Inc. (Sienna), a clinical stage company focused on medical dermatology and aesthetics, today announced it has completed a second closing of its Series A financing, securing an additional $12 million in equity capital and bringing the total capital raised to approximately $46 million. Read more »